A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
New Mexico attorney general launches probe of patient care at private equity-run hospital
New Mexico’s attorney general announced an investigation Tuesday into Memorial Medical Center, the Las Cruces hospital operated by Lifepoint...
-
Government watchdog says key federal health agency is failing on crises
WASHINGTON — The federal Department of Health and Human Services is failing to meet its responsibilities for leading the...
-
FDA approves drug to protect infants from RSV
IE 11 is not supported. For an optimal experience visit our site on another browser. Mysterious disappearance of Alabama...
-
Utah nurse arrested and accused of killing friend for life insurance payout
A Utah nurse is accused of killing a friend who she had convinced was sick with cancer so that...
-
San Francisco offering Pfizer, Moderna dose to Johnson & Johnson vaccine recipients
The San Francisco Department of Public Health will offer what it is calling a “supplemental” dose of the Pfizer...
-
Brazilians flock to the beach despite surge in Covid cases
IE 11 is not supported. For an optimal experience visit our site on another browser. 01:13 Share this –...
-
10 doctors on FDA panel for Abbott heart device had financial ties to the company
When the Food and Drug Administration recently convened a committee of advisers to assess a cardiac device made by...
-
CDC confirms Nevada dairy worker infected with different bird flu strain
A strain of bird flu spreading among dairy cows in Nevada has infected a dairy worker in the state,...
Recent Comments